Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Matsui

Showing results (71-80 of 101) with videos related to

Pageof 11
Sort By:
Molecular Cancer Therapeutics|July 4, 2012
The gamma secretase inhibitor MRK-003 attenuates pancreatic cancer growth in preclinical modelsMasamichi Mizuma, Zeshaan A Rasheed, Shinichi Yabuuchi, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2007
Hedgehog signaling maintains a tumor stem cell compartment in multiple myelomaCraig D Peacock, Qiuju Wang, Gregory S Gesell, et al.
Pancreas|October 9, 2019
Biphenotypic Differentiation of Pancreatic Cancer in 3-Dimensional CultureYoshihisa Matsushita, Barbara Smith, Michael Delannoy, et al.
Genome Research|March 7, 2012
A DNA hypermethylation module for the stem/progenitor cell signature of cancerHariharan Easwaran, Sarah E Johnstone, Leander Van Neste, et al.
The Journal of Clinical Investigation|February 9, 2023
PP2Ac/STRN4 negatively regulates STING-type I IFN signaling in tumor-associated macrophagesWinson S Ho, Isha Mondal, Beisi Xu, et al.
Oncogene|September 2, 2018
Hedgehog/GLI1 activation leads to leukemic transformation of myelodysplastic syndrome in vivo and GLI1 inhibition results in antitumor activityBonnie W Lau, Kyounghee Huh, Rafael Madero-Marroquin, et al.
Nature Communications|February 9, 2020
CD229 CAR T cells eliminate multiple myeloma and tumor propagating cells without fratricideSabarinath V Radhakrishnan, Tim Luetkens, Sandra D Scherer, et al.
Leukemia Research|February 12, 2008
Myeloablative allogeneic bone marrow transplant using T cell depleted allografts followed by post-transplant GM-CSF in high-risk myelodysplastic syndromesErica D Warlick, Paul V O'Donnell, Michael Borowitz, et al.
Cancer Cell|December 17, 2013
A bis-benzylidine piperidone targeting proteasome ubiquitin receptor RPN13/ADRM1 as a therapy for cancerRavi K Anchoori, Balasubramanyam Karanam, Shiwen Peng, et al.
American Journal of Hematology|December 7, 2010
Characterization of chronic myeloid leukemia stem cellsJonathan M Gerber, Lu Qin, Jeanne Kowalski, et al.
Pageof 11

Showing results (71-80 of 101) with videos related to

Sort By:
Pageof 11
Molecular Cancer Therapeutics|July 4, 2012
The gamma secretase inhibitor MRK-003 attenuates pancreatic cancer growth in preclinical modelsMasamichi Mizuma, Zeshaan A Rasheed, Shinichi Yabuuchi, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2007
Hedgehog signaling maintains a tumor stem cell compartment in multiple myelomaCraig D Peacock, Qiuju Wang, Gregory S Gesell, et al.
Pancreas|October 9, 2019
Biphenotypic Differentiation of Pancreatic Cancer in 3-Dimensional CultureYoshihisa Matsushita, Barbara Smith, Michael Delannoy, et al.
Genome Research|March 7, 2012
A DNA hypermethylation module for the stem/progenitor cell signature of cancerHariharan Easwaran, Sarah E Johnstone, Leander Van Neste, et al.
The Journal of Clinical Investigation|February 9, 2023
PP2Ac/STRN4 negatively regulates STING-type I IFN signaling in tumor-associated macrophagesWinson S Ho, Isha Mondal, Beisi Xu, et al.
Oncogene|September 2, 2018
Hedgehog/GLI1 activation leads to leukemic transformation of myelodysplastic syndrome in vivo and GLI1 inhibition results in antitumor activityBonnie W Lau, Kyounghee Huh, Rafael Madero-Marroquin, et al.
Nature Communications|February 9, 2020
CD229 CAR T cells eliminate multiple myeloma and tumor propagating cells without fratricideSabarinath V Radhakrishnan, Tim Luetkens, Sandra D Scherer, et al.
Leukemia Research|February 12, 2008
Myeloablative allogeneic bone marrow transplant using T cell depleted allografts followed by post-transplant GM-CSF in high-risk myelodysplastic syndromesErica D Warlick, Paul V O'Donnell, Michael Borowitz, et al.
Cancer Cell|December 17, 2013
A bis-benzylidine piperidone targeting proteasome ubiquitin receptor RPN13/ADRM1 as a therapy for cancerRavi K Anchoori, Balasubramanyam Karanam, Shiwen Peng, et al.
American Journal of Hematology|December 7, 2010
Characterization of chronic myeloid leukemia stem cellsJonathan M Gerber, Lu Qin, Jeanne Kowalski, et al.
Pageof 11